Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+
Options
Confirm
  • Product types
    0 selected
    Antibodies (298)
    Stable Cell Lines (1)
    Biosimilars (1)
    Assay Kit (419)
    Proteins (75)
    Research Biosimilar (157)
  • Expression system
    0 selected
    Mammalian Cells (185)
    E. coli (35)
    HEK293T (1)
  • Target
    0 selected
    SARS-CoV-2 Neutralization Antibody (3)
    Tavolimab (1)
    TIGIT & CD274/PD-L1 (1)
    Ixekizumab (1)
    Suvizumab (1)
    RBD (Omicron/BA.4/BA.5) (1)
    Cusatuzumab (1)
    Anetumab (1)
    Blosozumab (1)
    CD274/PD-L1 & TGFBR2/TGFR-2 (1)
    Varlilumab (1)
    Glycoprotein (5)
    Teclistamab (1)
    Sarilumab (2)
    RBD (Kappa) (1)
    Ascrinvacumab (1)
    Pembrolizumab (3)
    Avelumab (3)
    CD152/CTLA4 (86)
    Casirivimab (1)
    Daratumumab (3)
    β-D-Glucan (1)
    gC/Envelope glycoprotein C (1)
    Tezepelumab (1)
    IL6 (1)
    Protein A (1)
    Ziltivekimab (1)
    Carlumab (1)
    Indatuximab (1)
    Tigatuzumab (1)
    ATP7B (1)
    S100A14 (1)
    Lenzilumab (1)
    Semorinemab (1)
    Tremelimumab (1)
    CD274/PD-L1 & CD134/OX40 (1)
    T3E (1)
    S100A5 (4)
    Cixutumumab (1)
    Andecaliximab (1)
    Vofatamab (1)
    Trastuzumab (2)
    PD-L1 & TGF-Beta (1)
    Obinutuzumab (2)
    PD-L1 / VEGF-A (1)
    Daclizumab (1)
    Emibetuzumab (1)
    RBD (Omicron/BA.5) (3)
    Lirilumab (1)
    Remtolumab (1)
    Vorsetuzumab (1)
    DCT (2)
    Romosozumab (1)
    CD274/PD-L1 & CD137/TNFRSF9 (1)
    Romiplostim (2)
    M/Matrix protein (2)
    Rituximab (1)
    Enoblituzumab (1)
    TYRP1 (3)
    Gremubamab (1)
    RBD (Delta Plus) (1)
    Sintilimab (1)
    Durvalumab (3)
    Imdevimab (1)
    S100A4 (3)
    gC/UL44 (1)
    Magrolimab (1)
    Crizanlizumab (1)
    TRP-1 & CD3e (1)
    Tanezumab (1)
    Human β Amyloid (1-42) (1)
    S100A6 (1)
    LAG-3 & PD-1 (1)
    S100A10 (4)
    TPP15 (1)
    Namilumab (1)
    Tilavonemab (1)
    CTLA4 & PD1 (2)
    Zalifrelimab (1)
    T-cell surface antigen T3/Leu-4 epsilon chain (1)
    Infliximab (2)
    Dalotuzumab (1)
    Depatuxizumab (1)
    CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)
    Zanidatamab (1)
    Afutuzumab (1)
    Icrucumab (1)
    CD366/HAVCR2/TIM-3 (4)
    PDL1 (6)
    Elezanumab (1)
    Etanercept (3)
    NP/Nucleoprotein (3)
    CD20/MS4A1 (3)
    Secukinumab (2)
    Foravirumab (1)
    Elotuzumab (1)
    Ontamalimab (1)
    Eculizumab (3)
    Talacotuzumab (1)
    Tirzepatide (2)
    Pasotuxizumab (1)
    Mirzotamab (1)
    M1R (5)
    Semaglutide (2)
    Cinpanemab (1)
    Tislelizumab (1)
    Pacmilimab (1)
    CD274/PD-L1 & CD152/CTLA4 (1)
    CD223/LAG3 & CD279/PD-1 (4)
    Ifabotuzumab (1)
    Siltuximab (3)
    gD/US6 (1)
    Tocilizumab (3)
    Inclacumab (1)
    S100P (1)
    Human β Amyloid (1-40) (1)
    Cergutuzumab (1)
    KITLG/SCF (1)
    CD47/MER6 & PDCD1 / PD-1 / CD279 (1)
    Lorvotuzumab (1)
    Lintuzumab (1)
    TPP17 (1)
    Otilimab (1)
    Zagotenemab (1)
    IDO1 (2)
    CD274/PD-L1 & CD28 (1)
    T-cell surface glycoprotein CD3 epsilon chain (1)
    Figitumumab (1)
    Farletuzumab (1)
    S100A1 (2)
    SOX10 (3)
    S100A12 (1)
    Oxelumab (1)
    Losatuxizumab (1)
    Spike glycoprotein (RBD) (1)
    CD274/PD-L1 & CD28 & CD152/CTLA4 (1)
    Epcoritamab (1)
    Fluorescein & CD274/PD-L1 (1)
    Ibalizumab (1)
    S100a15a (1)
    US8/gE (1)
    Sibrotuzumab (1)
    HLA-A2-peptide (TDQVPFSV) Complex (1)
    RBD (6)
    RBD (Omicron/JN.1) (1)
    Codrituzumab (1)
    Mazdutide (2)
    NRAS (2)
    Rafivirumab (1)
    RBD (WT) (1)
    CD274/PD-L1 & TGFBR2 (1)
    Meplazumab (1)
    Mirikizumab (2)
    Aflibercept (1)
    Vibecotamab (1)
    Glycoprotein G (2)
    GP/Envelope glycoprotein (4)
    Rosopatamab (2)
    TYR/Tyrosinase (2)
    Omburtamab (1)
    Evolocumab (1)
    CD366/TIM-3 & CD274/PD-L1 (1)
    Toripalimab (1)
    CD279/PD-1 & CD152/CTLA4 (4)
    Denosumab (3)
    Tregalizumab (1)
    TRP-1 & CD47/MER6 (1)
    Adalimumab (3)
    S100A2 (1)
    TAU pT181 (1)
    Labetuzumab (1)
    B7-H1 / PD-L1 / CD274 & CD3E (1)
    Faricimab (1)
    TPP47 (1)
    TDP2 (1)
    Asp f 1/mitF (1)
    MITF (1)
    CD223 (1)
    Edrecolomab (1)
    S100A11 (2)
    S100A16 (1)
    Canakinumab (1)
    MLANA (4)
    Ganitumab (1)
    Mirvetuximab (1)
    Necitumumab (1)
    Zenocutuzumab (1)
    CD274/PD-L1/B7-H1 (5)
    Glofitamab (1)
    Ieramilimab (1)
    S100A13 (1)
    Cetuximab (3)
    Letolizumab (1)
    Imlifidase (5)
    Spike glycoprotein E2 (2)
    Enfortumab (1)
    RBD (Delta) (3)
    Dupilumab (3)
    RBD (Omicron/KP.2) (1)
    Tibulizumab (1)
    HLA-A2-peptide (ITDQVPFSV) Complex (4)
    RBD (Alpha) (1)
    p-Tyr (1)
    Glembatumumab (1)
    gG/US4 (2)
    PMEL17/ME20M (9)
    Tarextumab (1)
    H3L (3)
    Alirocumab (1)
    CD137/4-1BB & CD274/PD-L1 (3)
    CD79B (2)
    S100A8 (3)
    Nirsevimab (1)
    CD223/LAG3 & CD152/CTLA4 (1)
    Benufutamab (1)
    Zanolimumab (1)
    Lacnotuzumab (1)
    Olaratumab (1)
    TRP-1 & CD134/OX40 (1)
    TAU pT217 (1)
    Tisotumab (1)
    Oleclumab (1)
    Nesvacumab (1)
    G/Major surface glycoprotein G (1)
    Milatuzumab (1)
    Befovacimab (1)
    VSIR/VISTA & CD274/PD-L1 (1)
    Gevokizumab (1)
    Teprotumumab (1)
    VASH2/Vasohibin-2 (1)
    Bevacizumab (3)
    Panitumumab (3)
    EPO/Erythropoietin (1)
    cAMP (1)
    Ibritumomab (1)
    Palivizumab (3)
    CD47/MER6 & CD274/PD-L1 (2)
    sCD14 (1)
    Simlukafusp Alfa (1)
    Spike glycoprotein (10)
    CD340/ERBB2 (1)
    Astegolimab (1)
    LAG3 & PD-1 (1)
    Vunakizumab (1)
    HLA-A2-peptide (YLEPGPVT) Complex (4)
    Tosatoxumab (1)
    CD152/CTLA4 & CD279/PD-1 (1)
    RBD (Beta) (1)
    CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)
    Alacizumab (1)
    Balstilimab (1)
    Dilpacimab (1)
    Natalizumab (2)
    Exenatide acetate (2)
    gB/Envelope glycoprotein B (1)
    Omalizumab (2)
    Frovocimab (1)
    E8L (5)
    CD274/PD-L1 & CD279/PD-1 (1)
    Mavezelimab (1)
    CD80/B7-1 (20)
    Conatumumab (1)
    Tovetumab (1)
    CD279/PD-1 & CD274/PD-L1 (1)
    Certolizumab (2)
    Calprotectin (S100A8/9) (3)
    Cabiralizumab (1)
    CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)
    CD152/CTLA4 & CD274/PD-L1 (1)
    Vanucizumab (1)
    N/Nucleoprotein (1)
    PD-L1 & VEGF (1)
    Concizumab (1)
    Rolinsatamab (1)
    CD278/ICOS (1)
    Brolucizumab (1)
    Serclutamab (1)
    S100B (9)
    Clazakizumab (1)
    S100A9 (4)
    Mosunetuzumab (1)
    Afasevikumab (1)
    Suptavumab (1)
    F/Fusion glycoprotein F0 (5)
    Itolizumab (1)
    Ianalumab (1)
    CD274/PD-L1 & SLT-Ia (1)
    Spike Protein (Trimer) (2)
    Iscalimab (1)
    IL1RL1/ST2 (1)
    mitF/aspF1 (1)
    HLA-A2-peptide (KTWGQYWQV) Complex (2)
    RBD (Gamma) (1)
    Ramucirumab (1)
    Cetrelimab (1)
    Navicixizumab (1)
    Bimagrumab (1)
    gE/Envelope glycoprotein E (1)
    CD175/Tn (10)
    Urelumab (1)
    Lodelcizumab (1)
    A35R (5)
    CD366/TIM-3 & CD279/PD-1 (2)
    Ustekinumab (3)
    Ivuxolimab (1)
    Ocaratuzumab (1)
    Favezelimab (1)
    CD86/B7-2 (26)
    Drozitumab (1)
    Spike glycoprotein E1 (2)
    Eldelumab (1)
    Sacituzumab (1)
    PDL1 & VEGF (1)
    CD274/PD-L1 & CD3E (1)
    CD3E (1)
    Emactuzumab (1)
    Imalumab (1)
    Zampilimab (1)
    CD80&IL2 (1)
    Disitamab (1)
    Marstacimab (1)
    CD80/B7-1 & CD86/B7-2 (2)
    Basiliximab (1)
    Apamistamab (1)
    CD117/KIT (24)
    Ranibizumab (3)
    CD274/PD-L1 (81)
    CD366/TIM-3 (34)
    cGMP (1)
    Olokizumab (1)
    Pogalizumab (1)
    Bimekizumab (1)
    Guselkumab (3)
    Amatuximab (1)
    CD274/PD-L1 & VEGFA (1)
    NP/Nucleocapsid (5)
    dsDNA (1)
    Belantamab (1)
    Tiragolumab (2)
    Obiltoxaximab (1)
    CD19 & PD-L1 & CD3E & CD137 (1)
    FLT1/VEGFR1 & CD274/PD-L1 (1)
    RBD (E484K) (1)
    Nivolumab (3)
    Atezolizumab (3)
    Sotrovimab (1)
    Retatrutide (1)
    gD/Envelope glycoprotein D (1)
    Utomilumab (1)
    A29L (6)
    EGFR & CD3E & PD-L1 & 4-1BB (1)
    B6R/SL-159 (1)
    BSA (1)
    Sirukumab (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    BRAF/B-Raf (5)
    TYR (1)
    Abatacept (1)
    Lexatumumab (1)
    dsRNA (1)
    Ipilimumab (2)
    CD274/PD-L1 & CD47/MER6 (1)
    gp100 peptide-HLA Complex (1)
    Golimumab (3)
    CD47/MER6 & CD274/PD-L1/B7-H1 (2)
    CD223/LAG3 (41)
    CD152/CTLA4 & CD134/OX40 (1)
    Lupartumab (1)
    Pertuzumab (3)
    TFF3 (1)
    Anifrolumab (1)
    Camidanlumab (1)
    Varisacumab (1)
    Tesidolumab (1)
  • Species
    0 selected
    Mouse (24)
    Cat (1)
    Rat (1)
    Mus musculus (Mouse) (7)
    Tupaia chinensis (12)
    Homo sapiens (Human) (7)
    Canis lupus familiaris (Dog) (8)
    Neosartorya fumigata (1)
    Human (177)
    Dog (3)
    Canis lupus familiaris (1)
    Felis catus (Cat) (9)
  • Applications
    0 selected
    in vivo intra-tumoral regulatory T cell depletion (2)
    FCM (152)
    in vivo blockade (2)
    in vivo (2)
    Bioactivity: FACS (153)
    Blocking (2)
    SDS-PAGE (75)
    Functional assay (158)
    IP (2)
    SPR (4)
    Immunogen (75)
    Research in vivo (158)
    in vivo PD-L1 blockade (3)
    FuncS (18)
    Bioactivity testing in progress (31)
    IFA (4)
    in vitro PD-L1 blockade (3)
    ELISA (844)
    Neut (1)
    FACS (5)
    GICA (2)
    IHC-F (3)
    IHC (84)
    Inhib (1)
    Functional assay (6)
    WB (165)
    Neutralization (2)
    IF (8)
    in vivo CTLA-4 neutralization (2)
    Bioactivity: FACS (1)
    Research in vivo (4)
  • Reactivity
    0 selected
    Homo sapiens (Human) (4)
    Pig (6)
    Macaca mulatta (1)
    Mouse (81)
    Kryptolebias marmoratus (1)
    Carassius auratus (1)
    Pongo abelii (2)
    Human (199)
    Rat (16)
    Tupaia chinensis (4)
    Limanda limanda (1)
    Neosartorya fumigata (1)
    Cavia porcellus (1)
    Bos taurus (8)
    Mesocricetus auratus (1)
    Broad-Spectrum (1)
    Monkey (5)
    Cyprinus carpio (1)
    Oryctolagus cuniculus (4)
    Monodelphis domestica (1)
    Oryzias latipes (1)
    B7-H1 / PD-L1 / CD274 (1)
    Danio rerio (1)
    Callithrix jacchus (1)
    Avian retrovirus IC10 (1)
    Cynomolgus monkey (1)
    Xenopus laevis (1)
    Drosophila grimshawi (1)
    Capra hircus (1)
    Avian rous-associated virus type 1 (1)
    Mus musculus (Mouse) (1)
    Coturnix japonica (1)
    Rhesus macaque (1)
    Bovine (1)
    Drosophila willistoni (1)
    Chicken (4)
    Kirsten murine sarcoma virus (1)
    Cat (1)
    Dog (13)
  • Host species
    0 selected
    HEK293T (1)
    Human (157)
    Armenian Hamster (5)
    Rat (14)
    Humanized (34)
    Dog (2)
    Mouse (164)
    Chimeric (5)
    Alpaca (6)
    Rabbit (61)
  • Clonality
    0 selected
    Monoclonal (398)
    Polyclonal (53)
  • Conjugate
    0 selected
    PE (28)
    Unconjugated (301)
    FITC (28)
    APC (28)
    PerCP (28)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only